Pharmacological Inhibitors of Fatty Acid Synthase (FASN)-Catalyzed Endogenous Fatty Acid Biogenesis: A New Family of Anti-Cancer Agents?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|7|6|483-494

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.7, Iss.6, 2006-12, pp. : 483-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatty acid synthase inhibitors: new directions for oncology

By Kridel Steven J   Lowther W Todd   Pemble IV Charles W  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 11, 2007-11 ,pp. : 1817-1829

Informa Healthcare

Access to resources Recommend Favorite

Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents

By  

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 489-509

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Fatty Acid Analogues as Human Fatty Acid Synthase Thioesterase Domain Inhibitors: Synthesis and their Cytotoxicity Screening

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 6, 2015-07 ,pp. : 495-499

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors

By  

Current Drug Targets, Vol. 17, Iss. 15, 2016-12 ,pp. : 1735-1746

Bentham Science Publishers

Access to resources Recommend Favorite

Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics?

By  

Current Cancer Drug Targets, Vol. 3, Iss. 3, 2003-06 ,pp. : 219-236

Bentham Science Publishers

Access to resources Recommend Favorite